Xerostomia (Dry Mouth) Therapeutics Pipeline Market H2 2014 Review Report Available at RnRMarketResearch.com
Dallas, TX (PRWEB) February 18, 2015 -- The report “Xerostomia – Pipeline Review, H2 2014″ provides comprehensive information on the therapeutic development for Xerostomia. Xerostomia (Dry Mouth) is not a disease in itself. Xerostomia (dry mouth) may be a side-effect of medication. Drugs are a common cause of dry mouth. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report is available @ http://www.rnrmarketresearch.com/xerostomia-pipeline-review-h2-2014-market-report.html .
The report also reviews key players involved in the therapeutic development for Xerostomia and special features on late-stage and discontinued projects. Companies discussed in this Xerostomia – Pipeline Review, H2 2014 report include Acacia Pharma Ltd., Hadasit Medical Research Services & Development Ltd, Kadmon Corporation, LLC, Parion Sciences, Inc.
The signs and symptoms of Xerostomia include dry feeling in the mouth, stringy saliva, burning sensation in the mouth or on the tongue, cracks in the lips or at the corners of the mouth, tough tongue, difficulty chewing or swallowing and difficulty in talking. Drugs profile discussed in this report include APD-515, Gene Therapy to Activate Aquaporin-1 for Xerostomia, Gene Therapy to Activate Aquaporin-1 for Xerostomia, HYPER-IL-6, P-552. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=256150 . (This is a premium report priced at US$2000 for a single user License.)
Featured News & Press Releases cover by this “Xerostomia – Pipeline Review, H2 2014” report include: Oct 15, 2013: Acacia Pharma Announces Positive Phase II Results With APD515 for Xerostomia in Advanced Cancer; Jul 25, 2011: Acacia Pharma Initiates Phase II Clinical Trial With APD515 For Xerostomia; Feb 07, 2011: Acacia Pharma Completes Phase I Clinical Trial With APD515 For Xerostomia; Jan 06, 2011: Acacia Pharma Starts Clinical Trial With APD515 In Xerostomia.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of content
List of Tables
Number of Products under Development for Xerostomia, H2 2014
Number of Products under Development for Xerostomia - Comparative Analysis, H2 2014
Number of Products under Development by Companies, H2 2014
Number of Products under Investigation by Universities/Institutes, H2 2014
Comparative Analysis by Clinical Stage Development, H2 2014
Comparative Analysis by Early Stage Development, H2 2014
Products under Development by Companies, H2 2014
Products under Investigation by Universities/Institutes, H2 2014
Xerostomia - Pipeline by Acacia Pharma Ltd., H2 2014
Xerostomia - Pipeline by Hadasit Medical Research Services & Development Ltd, H2 2014
Xerostomia - Pipeline by Kadmon Corporation, LLC, H2 2014
Xerostomia - Pipeline by Parion Sciences, Inc., H2 2014
Assessment by Monotherapy Products, H2 2014
Number of Products by Stage and Target, H2 2014
Number of Products by Stage and Mechanism of Action, H2 2014
Number of Products by Stage and Route of Administration, H2 2014
Number of Products by Stage and Molecule Type, H2 2014
Xerostomia Therapeutics - Recent Pipeline Updates, H2 2014
Xerostomia - Dormant Projects, H2 2014
List of Figures
Number of Products under Development for Xerostomia, H2 2014
Number of Products under Development for Xerostomia - Comparative Analysis, H2 2014
Number of Products under Development by Companies, H2 2014
Comparative Analysis by Clinical Stage Development, H2 2014
Assessment by Monotherapy Products, H2 2014
Number of Products by Top 10 Targets, H2 2014
Number of Products by Stage and Top 10 Targets, H2 2014
Number of Products by Top 10 Mechanism of Actions, H2 2014
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014
Number of Products by Top 10 Routes of Administration, H2 2014
Number of Products by Stage and Top 10 Routes of Administration, H2 2014
Number of Products by Top 10 Molecule Types, H2 2014
Number of Products by Stage and Top 10 Molecule Types, H2 2014
Explore more reports on Oral Therapeutics Market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/oral-therapeutics .
About Us:
RnRMarketResearch.com is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers.
Ritesh Tiwari, RnR Market Research, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]
Share this article